The Only Complete Online Marketing Firm
Sunday, April 17, 2016
Opdivo Gets High Marks in Pre-Treated Melanoma (CME/CE)
(MedPage Today) -- PD-1 inhibitor leads to 5-year survival of 34%
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment